Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

Interleukin-21 Reduces Residual Immune Activation in ART-treated SIV-infected Rhesus Macaques

By Enthusiast Inc MDSeptember 29, 2014

…and critically contributes to non-AIDS-related morbidity and mortality in ART-treated individuals. Interleukin (IL)-21 regulates three immunological functions – Th17 cell homeostasis, differentiation of memory B cells, and longterm maintenance of…

A Surprising New Function of SAMHD1 as a Pro-Pathogenic Factor in HIV Infection

By Enthusiast Inc MDFebruary 27, 2015

…DNA intermediates by interferon gamma Inducible protein 16 (IFI16). Death occurs following caspase-1 activation in inflammasomes and the induction of pyroptosis, a highly inflammatory form of programmed cell death. These…

SARS-CoV-2–INFECTED MACAQUES EXHIBIT MICROBIAL TRANSLOCATION ACROSS INTESTINAL MUCOSA

By Jimmy He PharmD, DScApril 4, 2022

…mesenteric lymph node area in SARS-CoV-2 infected animals than control RM. Furthermore, soluble CD14 in plasma increased significantly from baseline to day 10 of SARS-CoV-2 infection (p=0.0006) and decreased significantly…

498 – Anti-IL-10/Anti-PD-1 Dual Blockade Leads to IFN-Related HIV Elite Control Signatures

By Jimmy He PharmD, DScMarch 20, 2025

…Methods In this study, flow cytometry, cytokine array, and single-cell RNA-Seq/ATAC-Seq were conducted on SIV-infected, virologically suppressed rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1 antibodies (combo-treatment) before analytical treatment…

VH GENE POLYMORPHISM ASSOCIATED WITH POTENT ANTI-SIV NEUTRALIZING ANTIBODY INDUCTION

By Jimmy He PharmD, DScApril 28, 2020

Induction of potent broadly-neutralizing antibodies (bNAbs) is a key for anti-HIV vaccine development. The boosting method for B-cell maturation toward bNAb induction has not been established, although recent studies have…

Dysbiotic Bacteria Translocate in Progressive SIV Infection

By Enthusiast Inc MDSeptember 29, 2014

…in the metabolic activity of bacteria within the GI tract. The biggest change being observed after the administration of anti-retroviral medication with increased metabolic activity of Proteobacteria. Probiotic treatment seemed…

Spatio-temporal Dynamics of Drug Resistance Evolution and Persistence of RT-SHIV

By Enthusiast Inc MDFebruary 16, 2016

…and DNA (vRNA and vDNA) were sampled from four different compartments (lymph node, vagina, gut and PBMC) in addition to plasma vRNA between 13 and 30 weeks post-infection. Compartmentalization was…

CHARACTERIZING HIV EXPRESSION IN VIVO

By Enthusiast Inc MDFebruary 15, 2017

…believed that such cells, when activated, are the source of viral rebound when ART is interrupted. However, it has been reported that HIV-expressing cells in lymph nodes may be protected…

NOVEL IMMUNOTHERAPY-BASED CURE INTERVENTIONS

By Jimmy He PharmD, DScApril 4, 2022

…ART alone is incapable of purging the pool of long-lived, tissue-resident, quiescent CD4+ T-cells harboring latent, replication-competent viral genomes. These ‘viral reservoirs’, maintained despite ART, comprise cells enriched for the…

IMMUNE-BASED INTERVENTIONS TARGETING INFLAMMATION AND VIRAL PERSISTENCE

By Enthusiast Inc MDFebruary 15, 2017

…a cure for HIV infection will not be achieved through ART intensification alone, and that novel approaches aimed at limiting residual inflammation and targeting persistently infected cells are needed. This…

←1
234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374
…7576777879…
808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top